Back to search

Article

TIAR-dependent coordination of alternative splicing and lipid peroxidation is required for CML cell resistance to imatinib in the bone marrow stroma

2026-05-30

Abstract excerpt

<h4>ABSTRACT</h4> Chronic myeloid leukemia (CML) is treated with Abl1 tyrosine kinase inhibitors (TKIs). Quiescent cancer cells residing in the bone marrow (BM) can survive the treatment and cause CML relapse. We previously found that a subset of alternative splicing (AS) changes detected in CML cells surviving months of therapy are initiated within hours of treatment onset. Here, we investigated how AS in CML ce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5b108aef-519c-551a-b0f3-c5259948654b
DOI
10.64898/2026.05.29.728710
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TIAR-dependent coordination of alternative splicing and lipid peroxidation is required for CML cell resistance to imatinib in the bone marrow stromaDOI 10.64898/2026.05.29.728710
Select a neighboring publication to make it the new centre.